This inventor holds 1 USPTO granted patent. Top assignees: Emory University, Georgia Tech Research Corporation. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2011
Title: Innovations in Ocular Drug Delivery by Ninghao Jiang
Introduction
Ninghao Jiang is an accomplished inventor based in Alexandria, VA (US). He has made significant contributions to the field of drug delivery, particularly in ocular applications. His innovative methods aim to enhance the administration of drugs to the eye, providing new solutions for patients.
Latest Patents
Ninghao Jiang holds a patent for a "Method for drug delivery to ocular tissue using microneedle." This patent describes methods and devices for administering a drug to a patient's eye. The techniques involve inserting a hollow microneedle into the sclera or corneal stroma without penetrating through it. The process includes infusing a fluid drug formulation through the microneedle and into the sclera or cornea. Additionally, the methods may involve partially retracting the microneedle before infusion to improve delivery. Alternatively, a solid microneedle can be used to create a pocket in the sclera or corneal stroma, allowing for the release of a drug formulation into the pocket to form a drug depot.
Career Highlights
Throughout his career, Ninghao Jiang has worked with notable institutions such as Georgia Tech Research Corporation and Emory University. His work has focused on advancing drug delivery technologies, particularly for ocular applications.
Collaborations
Ninghao Jiang has collaborated with esteemed colleagues, including Mark R Prausnitz and Henry F Edelhauser. These collaborations have contributed to the development of innovative solutions in the field of drug delivery.
Conclusion
Ninghao Jiang's contributions to ocular drug delivery through his patented methods demonstrate his commitment to improving patient care. His innovative approaches have the potential to transform how drugs are administered to the eye, paving the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile